Clinical trial Recruiting at 1 site Interventional Ages 50 and up

Digital Care for holistic health in older adults with diabetes and multiple conditions

Official title: Digital Care Community Common Good Program Enhances Holistic Health Management for Middle Aged and Older Adults With Diabetes Mellitus and Multiple Chronic Conditions

Run by Chang Gung University of Science and Technology · NCT07310849 · Data updated 2026-11-12

This study tests a digital care program to help adults 50+ with type 2 diabetes and other chronic diseases improve disease control, self-management, mood, and quality of life.

More Hypertension trials

Quick facts

Study typeInterventional
Ages50 Years and up
SexAll
Enrollment169 (estimated)
SponsorChang Gung University of Science and Technology
Academic / other
Locations1 site (New Taipei City, Wugu District)
StatusRecruiting
StartedMay 12, 2026
Main results expectedJune 1, 2027
Study endsJuly 1, 2027
Registry record updatedAugust 21, 2026
Trial IDNCT07310849 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 50 years or older with type 2 diabetes and at least one coexisting chronic condition, who own a smartphone, can use LINE, and reside in one of the four participating communities.

Probably not a fit

Participants with severe diabetes-related complications or certain psychiatric or cancer-related conditions may not experience benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study in New Taipei City assesses the Digital Care Community Common Good program against usual care. Over two years, researchers will build an integrated care team, expand an mHealth platform, create digital education for diabetes with comorbidities, and train community volunteers. About 169 eligible participants aged 50 and older with type 2 diabetes and at least one other chronic condition will be recruited from four communities and randomized to receive the digital program or usual care. The second year will include a 6-month intervention with effectiveness evaluation of the program's impact on disease control, self-management, depression, and quality of life. The study emphasizes community resources, smartphone-based tools, and LINE messaging to support participants in Mandarin or Taiwanese.

Why it matters

Potential benefit: If successful, participants could experience better diabetes and comorbidity control, improved self-management, and higher quality of life.

How similar studies have gone: Previous digital-health and community-embedded programs have shown improvements in self-management and quality of life, though this exact combination in older adults with multimorbidity is being tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age and Consent: Individuals aged 50 years or older who are willing to provide written informed consent.
* Language and Literacy: Participants must be literate and able to communicate in Mandarin or Taiwanese.
* Medical Diagnosis: Participants must have a physician-confirmed diagnosis of type 2 diabetes mellitus (T2DM) and at least one comorbid chronic disease (e.g., hypertension, hyperlipidemia, chronic kidney disease, or heart disease).
* Technology Use: Participants must own a smartphone and be willing to use the LINE messaging app and web-based health education links.
* Residence: Participants must reside within one of the four participating communities and have no plans to move away during the study intervention period.

Exclusion Criteria:

* Those with severe diabetes-related complications, such as renal failure, cerebrovascular disease, diabetic foot, or retinopathy.
* Individuals with psychiatric disorders, undergoing active cancer treatment, or those unable to perform independent self-care (e.g., due to visual impairment or mobility limitations).
* Individuals without diabetes but with other chronic diseases.
* Individuals residing in long-term care institutions.
* Individuals who are simultaneously participating in other intervention programs.

Where it's running

  • Wugu District Public Health Center,
    New Taipei City, Wugu District, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.